» Articles » PMID: 19917781

Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKD

Overview
Specialty Nephrology
Date 2009 Nov 18
PMID 19917781
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Left ventricular hypertrophy (LVH) associates with increased risk for cardiovascular disease. Hypertension leads to LVH in adults, but its role in the pathogenesis of LVH in children is not as well established. To examine left ventricular mass and evaluate factors associated with LVH in children with stages 2 through 4 chronic kidney disease (CKD), we analyzed cross-sectional data from children who had baseline echocardiography (n = 366) and underwent ambulatory BP monitoring (n = 226) as a part of the observational Chronic Kidney Disease in Children (CKiD) cohort study. At baseline, 17% of children had LVH (11% eccentric and 6% concentric) and 9% had concentric remodeling of the left ventricle. On the basis of a combination of ambulatory and casual BP assessment (n = 198), 38% of children had masked hypertension (normal casual but elevated ambulatory BP) and 18% had confirmed hypertension (both elevated casual and ambulatory BP). There was no significant association between LVH and kidney function. LVH was more common in children with either confirmed (34%) or masked (20%) hypertension compared with children with normal casual and ambulatory BP (8%). In multivariable analysis, masked (odds ratio 4.1) and confirmed (odds ratio 4.3) hypertension were the strongest independent predictors of LVH. In conclusion, casual BP measurements alone are insufficient to predict the presence of LVH in children with CKD. The high prevalence of masked hypertension and its association with LVH supports early echocardiography and ambulatory BP monitoring to evaluate cardiovascular risk in children with CKD.

Citing Articles

Clinical guidelines for the diagnosis, evaluation, and management of hypertension for Korean children and adolescents: the Korean Working Group of Pediatric Hypertension.

Park S, An H, Kim S, Kim S, Cho H, Kim J Kidney Res Clin Pract. 2025; 44(1):20-48.

PMID: 39923806 PMC: 11864819. DOI: 10.23876/j.krcp.24.096.


Association between extracellular DNA levels, markers of inflammation and left ventricular mass index in children with chronic kidney disease.

Lindblad Y, Tothova L, Celec P, Kublickiene K, Barany P, Chromek M Sci Rep. 2025; 15(1):2645.

PMID: 39838042 PMC: 11751163. DOI: 10.1038/s41598-025-86857-4.


Measurement of Blood Pressure in Children and Adolescents Outside the Office for the Diagnosis of Hypertension.

Nugent J Curr Cardiol Rep. 2025; 27(1):27.

PMID: 39826056 DOI: 10.1007/s11886-024-02178-4.


Investigation of a targeted panel of gut microbiome-derived toxins in children with chronic kidney disease.

Ebrahimi M, Hooper S, Mitsnefes M, Vasan R, Kimmel P, Warady B Pediatr Nephrol. 2025; .

PMID: 39820505 DOI: 10.1007/s00467-024-06580-6.


Ambulatory blood pressure profiles of children with asthma compared to healthy controls.

Koksoy A, Simsek Y, Epcacan S, Bayrakci U Pediatr Nephrol. 2025; .

PMID: 39753687 DOI: 10.1007/s00467-024-06615-y.


References
1.
Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R . Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr. 1997; 130(2):178-84. DOI: 10.1016/s0022-3476(97)70340-8. View

2.
McNiece K, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T . Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007; 50(2):392-5. PMC: 3582191. DOI: 10.1161/HYPERTENSIONAHA.107.092197. View

3.
Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago J . Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002; 105(21):2512-7. DOI: 10.1161/01.cir.0000017264.66561.3d. View

4.
Liu J, Roman M, Pini R, Schwartz J, Pickering T, Devereux R . Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999; 131(8):564-72. DOI: 10.7326/0003-4819-131-8-199910190-00003. View

5.
Brilla C, Funck R, Rupp H . Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000; 102(12):1388-93. DOI: 10.1161/01.cir.102.12.1388. View